Results 151 to 160 of about 8,921 (227)

Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice. [PDF]

Psychopharmacology (Berl)
McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC.   +5 more
europepmc   +1 more source

Psychedelic therapy and cultural humility. [PDF]

Transl Psychiatry
Gearin A, Docherty J, Sun X, Cheung EH, Tanuseputro P.   +4 more
europepmc   +1 more source

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness. [PDF]

Adv Sci (Weinh)
Alnagger NLN, Cardone P, Martial C, Perl YS, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason N, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Núñez P, Annen J.   +17 more
europepmc   +1 more source

Potential molecular pathways and therapeutic implications of rapid-acting antidepressants on myelin biology: a scoping review. [PDF]

Front Neurosci
Inserra A, Murray CJ, Campanale A, VanderZwaag J, Tremblay MÈ.   +4 more
europepmc   +1 more source

[Experiences with lysergic acid diethylamide (LSD 25)].

Arquivos de neuro-psiquiatria, 1998
openaire   +1 more source

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

JAMA Psychiatry
Mueller L, Santos de Jesus J, Schmid Y, Müller F, Becker A, Klaiber A, Straumann I, Luethi D, Haijen ECHM, Hurks PPM, Kuypers KPC, Liechti ME.   +11 more
europepmc   +1 more source